Skip to main content
. 2021 Feb 10;73(2):218–225. doi: 10.1007/s12070-021-02391-5

Table 1.

Epidemiological and clinical characteristics of patients with COVID 19 disease

Variables Total
n = 387
with OD
n = 167
without OD
n = 220
p value with GD
n = 153
without GD
n = 234
p value with OD & GD
n = 105
without OD & GD
n = 282
p value
Gender
Male 255 113 142 0.52 100 155 0.42 70 185 0.47
Female 132 54 78 53 79 35 97
Age group (years)
18–35 180 87 93 0.25 70 110 0.63 51 129 0.92
36–50 121 48 73 52 69 32 89
51–65 82 28 45 25 48 18 55
> 65 17 4 9 6 7 4 9
ILI Symptoms 228 123 105 < 0.001 132 96 < 0.001 92 136 < 0.001
Specific risk factor
HCW 81 35 46 0.49 35 46 0.22 26 55 0.12
Non HCW 306 132 174 118 188 79 227
Habits (Consume Alcohol, Smoking, tobacco chewing)
Present 66 32 34 0.16 30 36 0.14 24 42 0.03
Absent 321 135 186 123 198 81 240
Co Morbidities
Cadio-vascular diseases 59 24 35 0.81 29 30 0.36 18 41 0.52
Diabetes mellitus 32 13 19 0.76 14 18 0.61 11 21 0.33
CLD 11 5 6 0.87 6 5 0.3 5 6 0.16
CKD 2 2 0 2 0 2 0
Malignancy 2 2 0 2 0 2 0

Bold numbers signifies that p value is less than 0.05, which means all those factors in bold had significant chances of developing Olfactory and gustatory dysfunction

COVID 19 corona virus disease 2019, OD olfactory dysfunction, GD gustatory dysfunction, ILI influenza like illness, HCW health care worker, CLD chronic lung disease, CKD chronic kidney disease, CVD cardiovascular disease.